Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: genOway

Market Cap 2.5Cr 2.88Cr 2.3Cr 2.16Cr 4.03Cr 275.7Cr 4.12Cr 27Cr 11Cr 132.89Cr 11Cr 11Cr 462.08Cr P/E Ratio 2023 *
-
P/E Ratio 2024 -
Enterprise Value 2.56Cr 2.95Cr 2.36Cr 2.21Cr 4.13Cr 282.57Cr 4.22Cr 28Cr 11Cr 136.21Cr 11Cr 11Cr 473.6Cr EV / Sales 2023
1.64x
EV / Sales 2024 1.28x
Free-Float
79.77%
Yield 2023 *
-
Yield 2024 -
1 day-0.83%
1 week-2.86%
Current month-0.42%
1 month-3.25%
3 months-1.65%
6 months-3.25%
Current year-12.18%
1 week 2.38
Extreme 2.38
2.47
1 month 2.33
Extreme 2.33
2.5
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.5
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 01/03/1999
Director of Finance/CFO - 01/10/2015
Director TitleAgeSince
Director/Board Member - 01/03/1999
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
20/22/20Buy

Chief Executive Officer

12,500 0.1376%
17/21/17Sell

Chief Executive Officer

5,000 0.0553%
13/21/13Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
-0.83%-2.86%-31.21%-40.50% 2.55Cr
+1.20%+3.13%-14.16%-10.86% 4.3TCr
+3.50%-4.15%+265.85%+484.30% 3.17TCr
-0.61%-3.11%+14.00%-12.36% 3.02TCr
-1.27%-7.02%-0.82%+20.47% 2.89TCr
-0.66%-5.84%+7.59%+12.76% 2.39TCr
+2.01%+3.57%+57.15%+128.55% 1.36TCr
+0.09%-0.80%+6.59%+8.13% 1.3TCr
+2.77%-1.48% - - 1.34TCr
+0.68%-1.74%+103.98%+81.60% 1.22TCr
Average +0.69%-2.19%+45.44%+74.68% 2.1TCr
Weighted average by Cap. +0.79%-2.40%+53.63%+92.98%

Financials

2023 2024
Net sales 2.65Cr 3.05Cr 2.44Cr 2.29Cr 4.28Cr 292.51Cr 4.37Cr 29Cr 11Cr 141Cr 11Cr 11Cr 490.26Cr 2.75Cr 3.17Cr 2.54Cr 2.38Cr 4.44Cr 303.78Cr 4.54Cr 30Cr 12Cr 146.43Cr 12Cr 12Cr 509.14Cr
Net income 15.68L 18.06L 14.45L 13.54L 25.3L 17Cr 25.82L 1.72Cr 66.73L 8.34Cr 67.81L 66.35L 29Cr 18.31L 21.1L 16.88L 15.81L 29.54L 20Cr 30.16L 2.01Cr 77.94L 9.74Cr 79.2L 77.49L 34Cr
Net Debt 29.73L 34.26L 27.4L 25.68L 47.98L 33Cr 48.98L 3.27Cr 1.27Cr 16Cr 1.29Cr 1.26Cr 55Cr 6L 7L 6L 5L 10.05L 6.87Cr 10.26L 68.5L 26.52L 3.31Cr 26.95L 26.37L 12Cr
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
148
Date Price Change Volume
12/26/12 2.380 -0.83% 226
11/26/11 2.400 -0.83% 1,224
10/26/10 2.420 -0.41% 2,941
09/26/09 2.430 0.00% 2,067
08/26/08 2.430 -0.82% 3,130
  1. Stock Market
  2. Stocks
  3. ALGEN Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!